Selected research
Industry Growth & Trends
Global Medical Devices Genotoxicity Testing Service Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Medical Devices Genotoxicity Testing Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Medical Devices Genotoxicity Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Medical Devices Genotoxicity Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Medical Devices Genotoxicity Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Medical Devices Genotoxicity Testing Service market include TÜV SÜD, NAMSA, Eurofins Scientific, SGS SA, Nelson Labs, CD Bioarticle, UL Solutions, Measurlabs and STC Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Medical Devices Genotoxicity Testing Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Medical Devices Genotoxicity Testing Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Medical Devices Genotoxicity Testing Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Medical Devices Genotoxicity Testing Service.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Medical Devices Genotoxicity Testing Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Medical Devices Genotoxicity Testing Service Market by Company
TÜV SÜD
NAMSA
Eurofins Scientific
SGS SA
Nelson Labs
CD Bioarticle
UL Solutions
Measurlabs
STC Group
STEMart
Porsolt
TheraIndx
GBA Group
Adita Biosys
Adgyl Lifesciences
Medical Devices Genotoxicity Testing Service Segment by Type
In Vitro Testing
In Vivo Testing
Medical Devices Genotoxicity Testing Service Segment by Application
Implantable Devices
Polymer Devices
Drug Coating/Combination Devices
Others
Medical Devices Genotoxicity Testing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Devices Genotoxicity Testing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medical Devices Genotoxicity Testing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Devices Genotoxicity Testing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Medical Devices Genotoxicity Testing Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- In Vitro Testing
- In Vivo Testing
Applications
- Implantable Devices
- Polymer Devices
- Drug Coating/Combination Devices
- Others
Companies covered
- TÜV SÜD
- NAMSA
- Eurofins Scientific
- SGS SA
- Nelson Labs
- CD Bioarticle
- UL Solutions
- Measurlabs
- STC Group
- STEMart
- Porsolt
- TheraIndx
- GBA Group
- Adita Biosys
- Adgyl Lifesciences
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Medical Devices Genotoxicity Testing Service Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Medical Devices Genotoxicity Testing Service Market Size by Region (2021-2032)
- 1.4.1 Global Medical Devices Genotoxicity Testing Service Market Size by Region (2021-2026)
- 1.4.2 Global Medical Devices Genotoxicity Testing Service Market Size by Region (2027-2032)
- 1.5 Key Regions Medical Devices Genotoxicity Testing Service Market Size (2021-2032)
- 1.5.1 North America Medical Devices Genotoxicity Testing Service Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Medical Devices Genotoxicity Testing Service Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Medical Devices Genotoxicity Testing Service Market Size Growth Rate (2021-2032)
- 1.5.4 South America Medical Devices Genotoxicity Testing Service Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Medical Devices Genotoxicity Testing Service Market Size Growth Rate (2021-2032)
2 Medical Devices Genotoxicity Testing Service Market by Type
- 2.1 Type Introduction
- 2.1.1 In Vitro Testing
- 2.1.2 In Vivo Testing
- 2.2 Global Medical Devices Genotoxicity Testing Service Market Size by Type
- 2.2.1 Global Medical Devices Genotoxicity Testing Service Market Size Overview by Type (2021-2032)
- 2.2.2 Global Medical Devices Genotoxicity Testing Service Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Medical Devices Genotoxicity Testing Service Market Size Forecasted by Type (2027-2032)
- 2.3 Global Medical Devices Genotoxicity Testing Service Market Size by Regions
- 2.3.1 North America Medical Devices Genotoxicity Testing Service Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Medical Devices Genotoxicity Testing Service Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Medical Devices Genotoxicity Testing Service Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Medical Devices Genotoxicity Testing Service Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Medical Devices Genotoxicity Testing Service Market Size Breakdown by Type (2021-2026)
3 Medical Devices Genotoxicity Testing Service Market by Application
- 3.1 Type Introduction
- 3.1.1 Implantable Devices
- 3.1.2 Polymer Devices
- 3.1.3 Drug Coating/Combination Devices
- 3.1.4 Others
- 3.2 Global Medical Devices Genotoxicity Testing Service Market Size by Application
- 3.2.1 Global Medical Devices Genotoxicity Testing Service Market Size Overview by Application (2021-2032)
- 3.2.2 Global Medical Devices Genotoxicity Testing Service Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Medical Devices Genotoxicity Testing Service Market Size Forecasted by Application (2027-2032)
- 3.3 Global Medical Devices Genotoxicity Testing Service Market Size by Regions
- 3.3.1 North America Medical Devices Genotoxicity Testing Service Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Medical Devices Genotoxicity Testing Service Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Medical Devices Genotoxicity Testing Service Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Medical Devices Genotoxicity Testing Service Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Medical Devices Genotoxicity Testing Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Medical Devices Genotoxicity Testing Service Industry Trends
- 4.2 Medical Devices Genotoxicity Testing Service Industry Drivers
- 4.3 Medical Devices Genotoxicity Testing Service Industry Opportunities and Challenges
- 4.4 Medical Devices Genotoxicity Testing Service Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Medical Devices Genotoxicity Testing Service Revenue (2021-2026)
- 5.2 Global Medical Devices Genotoxicity Testing Service Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Medical Devices Genotoxicity Testing Service Key Company Headquarters & Area Served
- 5.4 Global Medical Devices Genotoxicity Testing Service Company, Product Type & Application
- 5.5 Global Medical Devices Genotoxicity Testing Service Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Medical Devices Genotoxicity Testing Service Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Medical Devices Genotoxicity Testing Service Players Market Share by Revenue in 2025
- 5.6.3 2025 Medical Devices Genotoxicity Testing Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 TÜV SÜD
- 6.1.1 TÜV SÜD Company Information
- 6.1.2 TÜV SÜD Business Overview
- 6.1.3 TÜV SÜD Medical Devices Genotoxicity Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 TÜV SÜD Medical Devices Genotoxicity Testing Service Product Portfolio
- 6.1.5 TÜV SÜD Recent Developments
- 6.2 NAMSA
- 6.2.1 NAMSA Company Information
- 6.2.2 NAMSA Business Overview
- 6.2.3 NAMSA Medical Devices Genotoxicity Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 NAMSA Medical Devices Genotoxicity Testing Service Product Portfolio
- 6.2.5 NAMSA Recent Developments
- 6.3 Eurofins Scientific
- 6.3.1 Eurofins Scientific Company Information
- 6.3.2 Eurofins Scientific Business Overview
- 6.3.3 Eurofins Scientific Medical Devices Genotoxicity Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Eurofins Scientific Medical Devices Genotoxicity Testing Service Product Portfolio
- 6.3.5 Eurofins Scientific Recent Developments
- 6.4 SGS SA
- 6.4.1 SGS SA Company Information
- 6.4.2 SGS SA Business Overview
- 6.4.3 SGS SA Medical Devices Genotoxicity Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 SGS SA Medical Devices Genotoxicity Testing Service Product Portfolio
- 6.4.5 SGS SA Recent Developments
- 6.5 Nelson Labs
- 6.5.1 Nelson Labs Company Information
- 6.5.2 Nelson Labs Business Overview
- 6.5.3 Nelson Labs Medical Devices Genotoxicity Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Nelson Labs Medical Devices Genotoxicity Testing Service Product Portfolio
- 6.5.5 Nelson Labs Recent Developments
- 6.6 CD Bioarticle
- 6.6.1 CD Bioarticle Company Information
- 6.6.2 CD Bioarticle Business Overview
- 6.6.3 CD Bioarticle Medical Devices Genotoxicity Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 CD Bioarticle Medical Devices Genotoxicity Testing Service Product Portfolio
- 6.6.5 CD Bioarticle Recent Developments
- 6.7 UL Solutions
- 6.7.1 UL Solutions Company Information
- 6.7.2 UL Solutions Business Overview
- 6.7.3 UL Solutions Medical Devices Genotoxicity Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 UL Solutions Medical Devices Genotoxicity Testing Service Product Portfolio
- 6.7.5 UL Solutions Recent Developments
- 6.8 Measurlabs
- 6.8.1 Measurlabs Company Information
- 6.8.2 Measurlabs Business Overview
- 6.8.3 Measurlabs Medical Devices Genotoxicity Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Measurlabs Medical Devices Genotoxicity Testing Service Product Portfolio
- 6.8.5 Measurlabs Recent Developments
- 6.9 STC Group
- 6.9.1 STC Group Company Information
- 6.9.2 STC Group Business Overview
- 6.9.3 STC Group Medical Devices Genotoxicity Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 STC Group Medical Devices Genotoxicity Testing Service Product Portfolio
- 6.9.5 STC Group Recent Developments
- 6.10 STEMart
- 6.10.1 STEMart Company Information
- 6.10.2 STEMart Business Overview
- 6.10.3 STEMart Medical Devices Genotoxicity Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 STEMart Medical Devices Genotoxicity Testing Service Product Portfolio
- 6.10.5 STEMart Recent Developments
- 6.11 Porsolt
- 6.11.1 Porsolt Company Information
- 6.11.2 Porsolt Business Overview
- 6.11.3 Porsolt Medical Devices Genotoxicity Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Porsolt Medical Devices Genotoxicity Testing Service Product Portfolio
- 6.11.5 Porsolt Recent Developments
- 6.12 TheraIndx
- 6.12.1 TheraIndx Company Information
- 6.12.2 TheraIndx Business Overview
- 6.12.3 TheraIndx Medical Devices Genotoxicity Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 TheraIndx Medical Devices Genotoxicity Testing Service Product Portfolio
- 6.12.5 TheraIndx Recent Developments
- 6.13 GBA Group
- 6.13.1 GBA Group Company Information
- 6.13.2 GBA Group Business Overview
- 6.13.3 GBA Group Medical Devices Genotoxicity Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 GBA Group Medical Devices Genotoxicity Testing Service Product Portfolio
- 6.13.5 GBA Group Recent Developments
- 6.14 Adita Biosys
- 6.14.1 Adita Biosys Company Information
- 6.14.2 Adita Biosys Business Overview
- 6.14.3 Adita Biosys Medical Devices Genotoxicity Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Adita Biosys Medical Devices Genotoxicity Testing Service Product Portfolio
- 6.14.5 Adita Biosys Recent Developments
- 6.15 Adgyl Lifesciences
- 6.15.1 Adgyl Lifesciences Company Information
- 6.15.2 Adgyl Lifesciences Business Overview
- 6.15.3 Adgyl Lifesciences Medical Devices Genotoxicity Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Adgyl Lifesciences Medical Devices Genotoxicity Testing Service Product Portfolio
- 6.15.5 Adgyl Lifesciences Recent Developments
7 North America
- 7.1 North America Medical Devices Genotoxicity Testing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Medical Devices Genotoxicity Testing Service Market Size by Country (2021-2026)
- 7.3 North America Medical Devices Genotoxicity Testing Service Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Medical Devices Genotoxicity Testing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Medical Devices Genotoxicity Testing Service Market Size by Country (2021-2026)
- 8.3 Europe Medical Devices Genotoxicity Testing Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Medical Devices Genotoxicity Testing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Medical Devices Genotoxicity Testing Service Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Medical Devices Genotoxicity Testing Service Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Medical Devices Genotoxicity Testing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Medical Devices Genotoxicity Testing Service Market Size by Country (2021-2026)
- 10.3 South America Medical Devices Genotoxicity Testing Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Medical Devices Genotoxicity Testing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Medical Devices Genotoxicity Testing Service Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Medical Devices Genotoxicity Testing Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst